279 related articles for article (PubMed ID: 25465324)
41. Effect of High-Dose Statin Therapy on Drug-Eluting Stent Strut Coverage.
Kim JS; Kim JH; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2460-7. PubMed ID: 26359512
[TBL] [Abstract][Full Text] [Related]
42. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study.
Unverdorben M; Vallbracht C; Cremers B; Heuer H; Hengstenberg C; Maikowski C; Werner GS; Antoni D; Kleber FX; Bocksch W; Leschke M; Ackermann H; Boxberger M; Speck U; Degenhardt R; Scheller B
EuroIntervention; 2015 Dec; 11(8):926-34. PubMed ID: 25169589
[TBL] [Abstract][Full Text] [Related]
43. Long-term vascular healing in response to sirolimus- and paclitaxel-eluting stents: an optical coherence tomography study.
Räber L; Baumgartner S; Garcia-Garcia HM; Kalesan B; Justiz J; Pilgrim T; Moschovitis A; Khattab AA; Buellesfeld L; Wenaweser P; Meier B; Serruys PW; Jüni P; Windecker S
JACC Cardiovasc Interv; 2012 Sep; 5(9):946-57. PubMed ID: 22995882
[TBL] [Abstract][Full Text] [Related]
44. Randomised comparison of strut coverage between Nobori biolimus-eluting and sirolimus-eluting stents: an optical coherence tomography analysis.
Kim BK; Ha J; Mintz GS; Kim JS; Shin DH; Ko YG; Choi D; Jang Y; Hong MK
EuroIntervention; 2014; 9(12):1389-97. PubMed ID: 24531309
[TBL] [Abstract][Full Text] [Related]
45. Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study.
Adriaenssens T; Dens J; Ughi G; Coosemans M; Onsea K; Dubois C; Sinnaeve P; Vrolix M; Desmet W
EuroIntervention; 2011 May; 7 Suppl K():K100-5. PubMed ID: 22027717
[TBL] [Abstract][Full Text] [Related]
46. Serial Optical Coherence Tomography Evaluation at 6, 12, and 24 Months After Biolimus A9-Eluting Biodegradable Polymer-Coated Stent Implantation.
Konishi A; Shinke T; Otake H; Takaya T; Osue T; Kinutani H; Kuroda M; Takahashi H; Terashita D; Shite J; Hirata K
Can J Cardiol; 2015 Aug; 31(8):980-8. PubMed ID: 26117623
[TBL] [Abstract][Full Text] [Related]
47. Six-month outcomes of the XINSORB bioresorbable sirolimus-eluting scaffold in treating single de novo lesions in human coronary artery.
Wu Y; Shen L; Ge L; Wang Q; Qian J; Zhang F; Yao K; Huang D; Chen Y; Ge J
Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():630-7. PubMed ID: 26864162
[TBL] [Abstract][Full Text] [Related]
48. In-stent fractional flow reserve variations and related optical coherence tomography findings: the FFR-OCT co-registration study.
Pyxaras SA; Adriaenssens T; Barbato E; Ughi GJ; Di Serafino L; De Vroey F; Toth G; Tu S; Reiber JHC; Bax JJ; Wijns W
Int J Cardiovasc Imaging; 2018 Apr; 34(4):495-502. PubMed ID: 29080150
[TBL] [Abstract][Full Text] [Related]
49. Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography data.
Bourantas CV; Serruys PW; Nakatani S; Zhang YJ; Farooq V; Diletti R; Ligthart J; Sheehy A; van Geuns RJ; McClean D; Chevalier B; Windecker S; Koolen J; Ormiston J; Whitbourn R; Rapoza R; Veldhof S; Onuma Y; Garcia-Garcia HM
EuroIntervention; 2015 Nov; 11(7):746-56. PubMed ID: 25308301
[TBL] [Abstract][Full Text] [Related]
50. Rationale and study design of the RESERVOIR trial: a randomized trial comparing reservoir-based polymer-free amphilimus-eluting stents versus everolimus-eluting stents with durable polymer in patients with diabetes mellitus.
Romaguera R; Brugaletta S; Gomez-Lara J; Pinar E; Jiménez-Quevedo P; Gracida M; Roura G; Ferreiro JL; Teruel L; Gómez-Hospital JA; Montanya E; Alfonso F; Valgimigli M; Sabate M; Cequier A
Catheter Cardiovasc Interv; 2015 Mar; 85(4):E116-22. PubMed ID: 25380051
[TBL] [Abstract][Full Text] [Related]
51. A head to head comparison of XINSORB bioresorbable sirolimus-eluting scaffold versus metallic sirolimus-eluting stent: 180 days follow-up in a porcine model.
Shen L; Wu Y; Ge L; Zhang Y; Wang Q; Qian J; Qiu Z; Ge J
Int J Cardiovasc Imaging; 2017 Oct; 33(10):1473-1481. PubMed ID: 28639098
[TBL] [Abstract][Full Text] [Related]
52. Colocalization of thin-cap fibroatheroma and spotty calcification is a powerful predictor of procedure-related myocardial injury after elective coronary stent implantation.
Ueda T; Uemura S; Watanabe M; Sugawara Y; Soeda T; Okayama S; Takeda Y; Kawata H; Kawakami R; Saito Y
Coron Artery Dis; 2014 Aug; 25(5):384-91. PubMed ID: 24681754
[TBL] [Abstract][Full Text] [Related]
53. Preclinical randomised safety, efficacy and physiologic study of the silicon dioxide inert-coated Axetis and bare metal stent: short-, mid- and long-term outcome.
Pavo N; Syeda B; Bernhart A; Szentirmai E; Hemetsberger R; Samaha E; Plass C; Zlabinger K; Pavo IJ; Petrasi Z; Petnehazy Ö; Hoerstrup SP; Maurer G; Gyöngyösi M
EuroIntervention; 2015 Aug; 11(4):433-41. PubMed ID: 24769439
[TBL] [Abstract][Full Text] [Related]
54. First report of a novel polymer-free dual-drug eluting stent in de novo coronary artery disease: results of the first in human BICARE trial.
Yu M; Xu B; Kandzari DE; Wu Y; Yan H; Chen J; Qian J; Qiao S; Yang Y; Gao RL
Catheter Cardiovasc Interv; 2014 Feb; 83(3):405-11. PubMed ID: 23857821
[TBL] [Abstract][Full Text] [Related]
55. Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients: the randomized Diabetes and Drug-Eluting Stent (DiabeDES) IV Intravascular Ultrasound trial.
Antonsen L; Maeng M; Thayssen P; Christiansen EH; Hansen KN; Kaltoft A; Hansen HS; Thuesen L; Lassen JF; Jensen LO
Catheter Cardiovasc Interv; 2014 May; 83(6):864-72. PubMed ID: 23996918
[TBL] [Abstract][Full Text] [Related]
56. Drug-eluting stent implantation in patients with acute coronary syndrome - the Activity of Platelets after Inhibition and Cardiovascular Events: Optical Coherence Tomography (APICE OCT) study.
Chieffo A; Buchanan GL; Parodi G; Versaci F; Bianchi RM; Valenti R; Saccà S; Mongiardo A; Span S; Migliorini A; Spaccarotella C; Reimers B; Antoniucci D; Indolfi C; Ferrari A; Maehara A; Mintz GS; Colombo A
EuroIntervention; 2014 Dec; 10(8):916-23. PubMed ID: 24974806
[TBL] [Abstract][Full Text] [Related]
57. Optical coherence tomography versus intravascular ultrasound to evaluate coronary artery disease and percutaneous coronary intervention.
Bezerra HG; Attizzani GF; Sirbu V; Musumeci G; Lortkipanidze N; Fujino Y; Wang W; Nakamura S; Erglis A; Guagliumi G; Costa MA
JACC Cardiovasc Interv; 2013 Mar; 6(3):228-36. PubMed ID: 23517833
[TBL] [Abstract][Full Text] [Related]
58. Healthy Strut Coverage After Coronary Stent Implantation: An Ex Vivo Human Autopsy Study.
Jinnouchi H; Otsuka F; Sato Y; Bhoite RR; Sakamoto A; Torii S; Yahagi K; Cornelissen A; Mori M; Kawakami R; Kolodgie FD; Virmani R; Finn AV
Circ Cardiovasc Interv; 2020 May; 13(5):e008869. PubMed ID: 32338525
[TBL] [Abstract][Full Text] [Related]
59. Long-term outcomes of neointimal hyperplasia without neoatherosclerosis after drug-eluting stent implantation.
Kim JS; Lee JH; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
JACC Cardiovasc Imaging; 2014 Aug; 7(8):788-95. PubMed ID: 25051946
[TBL] [Abstract][Full Text] [Related]
60. Impact of an endothelial progenitor cell capturing stent on coronary microvascular function: comparison with drug-eluting stents.
Choi WG; Kim SH; Yoon HS; Lee EJ; Kim DW
Korean J Intern Med; 2015 Jan; 30(1):42-8. PubMed ID: 25589834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
